Status:
COMPLETED
Bioequivalence Trial of a New Opioid Combination Compared to Reference
Lead Sponsor:
Grünenthal GmbH
Conditions:
Healthy
Eligibility:
MALE
18-45 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to demonstrate bioequivalence of a new formulation to a reference
Eligibility Criteria
Inclusion
- Standard Phase I
- Cyp 2D6 extensive metabolizers
Exclusion
- Standard Phase I
- Contraindications of current reference tablet SmPC
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
End Date :
March 1 2007
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00460785
Start Date
February 1 2007
End Date
March 1 2007
Last Update
July 6 2007
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.